WSFS
ANIP icon

Wilmington Savings Fund Society’s ANI Pharmaceuticals ANIP Stock Holding History

Wilmington Savings Fund Society’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-28
Closed -$1.83K – 1403
2025
Q2 		$1.83K Buy
+28
New +$1.82K ﹤0.01% 1926

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wilmington Savings Fund Society's ANIP Position: Q3 2025 in Review

Wilmington Savings Fund Society sold out of ANI Pharmaceuticals (ANIP) in Q3 2025, closing a stake of 28 shares — an estimated $1.83K sold.

Wilmington Savings Fund Society first reported a position in ANIP in Q2 2025 and held it in 1 quarter. The position peaked at $1.83K in Q2 2025. 269 funds tracked by Wall St. Rank hold ANIP as of Q3 2025.

  • Wilmington Savings Fund Society reported no remaining ANI Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 28 ANI Pharmaceuticals shares in Q3 2025, an estimated $1.83K.
  • Wilmington Savings Fund Society first reported a position in ANI Pharmaceuticals in Q2 2025 and held it in 1 quarter.
  • Wilmington Savings Fund Society's ANI Pharmaceuticals position peaked at $1.83K in Q2 2025.
  • 269 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2025.

Based on Wilmington Savings Fund Society's 13F filing for Q3 2025, filed 28 Oct 2025.